Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, today announces that the first patient has been enrolled in the Phase 1 clinical trial of its drug candidate 177Lu ...

Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial ...

With more than 40% of U.S. adults having been diagnosed with liver disease, Virginia Commonwealth University (VCU) research suggests that there might be a way to treat fatty liver disease.

Verona Pharma’s Ohtuvayre generated $71.3M in Q1'25 sales, signaling blockbuster potential. Read more on VRNA’s upcoming ...

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and ...

Equity Insider News Commentary ? Optimism in the field of oncology is on the rise, thanks to the National Institutes of Health's latest annual report, which showed a steady decline in cancer death ...

There's no need to track down complicated and obscure businesses. Some of the market's best income-producing stocks are ...

For decades, scientists and surgeons around the world have been trying to solve the organ donor crisis. The answer could be ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

A traditional day for labor marches provided an opportunity for protesters across the country to demonstrate opposition to ...

Individuals in Western Wisconsin seeking state-of-the-art treatment for depression without medication, pain or downtime, can turn to Driftless Medical Spa in Prairie Du Chien, the first center in ...

Blueprint Medicines Corporation ( NASDAQ: BPMC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET ...